Pharming Group N.V. Sponsored ADR (PHAR)

Last Closing Price: 17.08 (2026-04-22)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Pharming Group N.V. Sponsored ADR (PHAR) had Net Income of $5.47M for the most recently reported fiscal quarter, ending 2025-12-31.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
$106.54M
Net Income
$5.47M
$21.08M
$85.46M
$100.25M
$6.29M
$-1.45M
$4.83M
$4.83M
$5.33M
$5.33M
$5.33M
$5.33M
$6.29M
$9.49M
68.88M
74.69M
$0.08
$0.10
Balance Sheet Financials
$299.47M
$7.23M
$200.49M
$499.96M
$115.79M
$92.72M
$107.07M
$222.86M
$277.10M
$141.56M
$277.10M
70.17M
Cash Flow Statement Financials
$54.71M
$26.25M
$1.50M
$54.94M
$145.31M
$90.36M
$13.77M
--
--
Fundamental Metrics & Ratios
2.59
--
--
0.25
0.35
80.22%
5.90%
5.90%
--
4.54%
5.13%
$53.96M
--
--
--
0.21
0.32
1.95
46.21
1.92%
3.76%
1.07%
1.44%
$3.95
$0.72
$0.73